Clinical Trials in Salt Lake City

Showing 8341-8360 of 16,694 trials

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

NCT03764072

This study will evaluate the dose-response relationship and safety of VX-150 in treating acute pain following bunionectomy.

Acute Pain

Vertex Pharmaceuticals Incorporated250 participantsStarted Dec 2018

Phoenix, Arizona, United States • Anaheim, California, United States • Pasadena, California, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

NCT00326898

This randomized phase III trial studies sunitinib malate to see how well it works compared to sorafenib tosylate or placebo in treating patients with kidney cancer that has been removed by surgery. Sunitinib malate and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib malate or sorafenib tosylate after surgery may kill any tumor cells that remain after surgery. It is not yet known whether sunitinib malate is more effective than sorafenib tosylate or placebo in treating kidney cancer.

Clear Cell Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7Stage II Renal Cell Cancer AJCC v7+1 more

National Cancer Institute (NCI)1,943 participantsStarted Apr 2006

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Mobile, Alabama, United States +984 more locations

A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Find Trials by Condition in Salt Lake City

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Feasibility of Telemedicine Medical Abortion

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients

Mind the Gap (AIR-B3)

Building Better Bridges Randomized Control Trial

Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

Safety Study of MGA271 in Refractory Cancer

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis

ACell MatriStem Pelvic Floor Matrix Versus Native Tissue Repair, Comparative Study

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer